Hydroxyphenylazopyrimidines: characterization of the active forms and their inhibitory action on a DNA polymerase from Bacillus subtilis.
The active forms of 6-(p-hydroxyphenylazo)-uracil and 6-(p-hydroxyphenylazo)-isocytosine were isolated and identified as their respective hydrazino derivatives. These arylhydrazino pyrimidines selectively inhibited a chromatographically distinct DNA polymerase from Bacillus subtilis. The actions of the reduced drugs on this polymerase were identical to those observed on ATP-dependent DNA synthesis in toluene-treated cells; dGTP competitively antagonized the inhibitory activity of the uracil derivative, and dATP competitively antagonized that of the isocytosine derivative. Analysis of the interactions of the arylhydrazinopyrimidines and nucleic acid bases by nuclear magnetic resonance suggested that hydroxyphenylhydrazino-uracil and hydroxyphenylhydrazino-isocytosine pair in a novel manner with, respectively, cytosine and thymine. A mechanism of inhibitor action, involving binding of the reduced drugs to enzyme and the pyrimidines of DNA template, is proposed.
D000255:Adenosine Triphosphate / Q000494:pharmacology; D001391:Azo Compounds / Q000494:pharmacology; D001412:Bacillus subtilis / Q000201:enzymology* / Q000378:metabolism; D002247:Carbon Isotopes; D002848:Chromatography, DEAE-Cellulose; D003596:Cytosine / Q000494:pharmacology*; D004254:DNA Nucleotidyltransferases / Q000037:antagonists & inhibitors* / Q000302:isolation & purification; D006160:Guanosine Triphosphate / Q000494:pharmacology; D009682:Magnetic Resonance Spectroscopy; D010084:Oxidation-Reduction; D010636:Phenols / Q000494:pharmacology; D014498:Uracil / Q000494:pharmacology*
D001391:Azo Compounds; D002247:Carbon Isotopes; D010636:Phenols; D014498:Uracil; D006160:Guanosine Triphosphate; D003596:Cytosine; D000255:Adenosine Triphosphate; D004254:DNA Nucleotidyltransferases